Timmons D, Montrief T, Koyfman A, Long B
Exploring semaglutides effects on heart rate involves reviewing the latest clinical research to understand how and why these changes occur
Semaglutide is a long-acting GLP-1 analog developed by Novo Nordisk, which only requires subcutaneous injection once a week and is still in clinical phase III currently
Almost everyone experiences side effects such as fatigue, irritability, and difficulty concentrating during fasting periods especially at the beginning
Timing Considerations Because GLP-1 medications can influence metabolism and potentially early pregnancy, many reproductive endocrinologists recommend pausing these medications when trying to conceive or during IVF cycles
*Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality.